Skip to main content
Erschienen in: Pediatric Cardiology 7/2020

11.09.2020 | Review Article

Pharmacologic Control of Blood Pressure in Infants and Children

verfasst von: Joseph D. Tobias, Aymen Naguib, Janet Simsic, Catherine D. Krawczeski

Erschienen in: Pediatric Cardiology | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Alterations in blood pressure are common during the perioperative period in infants and children. Perioperative hypertension may be the result of renal failure, volume overload, or activation of the sympathetic nervous system. Concerns regarding end-organ effects or postoperative bleeding may mandate regulation of blood pressure. During the perioperative period, various pharmacologic agents have been used for blood pressure control including sodium nitroprusside, nitroglycerin, β-adrenergic antagonists, fenoldopam, and calcium channel antagonists. The following manuscript outlines the commonly used pharmacologic agents for perioperative BP including dosing regimens and adverse effect profiles. Previously published clinical trials are discussed and efficacy in the perioperative period reviewed.
Literatur
1.
Zurück zum Zitat Seltzer JL (1987) Etiology and prevention of perioperative hypertension. Surg Rounds 10:711–724 Seltzer JL (1987) Etiology and prevention of perioperative hypertension. Surg Rounds 10:711–724
2.
Zurück zum Zitat Flynn JT (2009) Hypertension in the young: epidemiology, sequelae, and therapy. Nephrol Dial Transpl 24:370–375CrossRef Flynn JT (2009) Hypertension in the young: epidemiology, sequelae, and therapy. Nephrol Dial Transpl 24:370–375CrossRef
3.
Zurück zum Zitat Flynn JT, Tullus K (2009) Severe hypertension in children and adolescents: pathophysiology and treatment. Pediatr Nephrol 24:1101–1112CrossRefPubMed Flynn JT, Tullus K (2009) Severe hypertension in children and adolescents: pathophysiology and treatment. Pediatr Nephrol 24:1101–1112CrossRefPubMed
4.
Zurück zum Zitat Baker-Smith CM, Flynn SK, Flynn JT et al (2018) Subcommittee on screening and management of high BP in children. Diagnosis, evaluation, and management of high blood pressure in children and adolescents. Pediatrics 42:20182096CrossRef Baker-Smith CM, Flynn SK, Flynn JT et al (2018) Subcommittee on screening and management of high BP in children. Diagnosis, evaluation, and management of high blood pressure in children and adolescents. Pediatrics 42:20182096CrossRef
6.
Zurück zum Zitat Donnelly JE, Young AMH, Brady K (2017) Autoregulation in paediatric TBI-current evidence and implications for treatment. Childs Nerv Syst 33:1735–1744CrossRefPubMed Donnelly JE, Young AMH, Brady K (2017) Autoregulation in paediatric TBI-current evidence and implications for treatment. Childs Nerv Syst 33:1735–1744CrossRefPubMed
7.
Zurück zum Zitat Easley RB, Marino BS, Jennings J, Cassedy AE, Kibler KK, Brady KM, Andropoulos DB, Brunetti M, Hogue CW, Heitmiller ES, Lee JK, Spaeth J, Everett AD (2018) Impaired cerebral autoregulation and elevation in plasma glial fibrillary acidic protein level during cardiopulmonary bypass surgery for CHD. Cardiol Young 28:55–65CrossRefPubMed Easley RB, Marino BS, Jennings J, Cassedy AE, Kibler KK, Brady KM, Andropoulos DB, Brunetti M, Hogue CW, Heitmiller ES, Lee JK, Spaeth J, Everett AD (2018) Impaired cerebral autoregulation and elevation in plasma glial fibrillary acidic protein level during cardiopulmonary bypass surgery for CHD. Cardiol Young 28:55–65CrossRefPubMed
8.
Zurück zum Zitat Marik PE, Varon J (2009) Perioperative hypertension: a review of current and emerging therapeutic agents. J Clin Anesth 21:220–229CrossRefPubMed Marik PE, Varon J (2009) Perioperative hypertension: a review of current and emerging therapeutic agents. J Clin Anesth 21:220–229CrossRefPubMed
9.
Zurück zum Zitat Desai R, Muntazar M, Goldberg ME (2009) Strategies for managing perioperative hypertension. Curr Hyperten Rep 11:173–177CrossRef Desai R, Muntazar M, Goldberg ME (2009) Strategies for managing perioperative hypertension. Curr Hyperten Rep 11:173–177CrossRef
11.
Zurück zum Zitat Playfair L (1849) On the nitroprusside: a new class of salts. Philos Trans R Soc Lond 139:41–51 Playfair L (1849) On the nitroprusside: a new class of salts. Philos Trans R Soc Lond 139:41–51
12.
Zurück zum Zitat Johnson C (1928) Mechanisms of actions and toxicity of nitroprusside. Exp Biol Med 26:2–6CrossRef Johnson C (1928) Mechanisms of actions and toxicity of nitroprusside. Exp Biol Med 26:2–6CrossRef
13.
Zurück zum Zitat Page IH, Corcoran AC, Dustan HP, Koppanyi T (1955) Cardiovascular actions of sodium nitroprusside in animals and hypertensive patients. Circulation 11:188–198PubMedCrossRef Page IH, Corcoran AC, Dustan HP, Koppanyi T (1955) Cardiovascular actions of sodium nitroprusside in animals and hypertensive patients. Circulation 11:188–198PubMedCrossRef
14.
Zurück zum Zitat Moraca PP, Bitte EM, Hale DE, Wasmuth CE, Poutasse EGF (1962) Clinical evaluation of sodium nitroprusside as a hypotensive agent. Anesthesiology 23:193–199CrossRefPubMed Moraca PP, Bitte EM, Hale DE, Wasmuth CE, Poutasse EGF (1962) Clinical evaluation of sodium nitroprusside as a hypotensive agent. Anesthesiology 23:193–199CrossRefPubMed
15.
Zurück zum Zitat Jones GOM, Cole P (1968) Sodium nitroprusside as a hypotensive agent. Br J Anaesth 40:804–808PubMed Jones GOM, Cole P (1968) Sodium nitroprusside as a hypotensive agent. Br J Anaesth 40:804–808PubMed
16.
Zurück zum Zitat Taylor TH, Styles M, Lamming AJ (1970) Sodium nitroprusside as a hypotensive agent in general anaesthesia. Br J Anaesth 42:859–864CrossRefPubMed Taylor TH, Styles M, Lamming AJ (1970) Sodium nitroprusside as a hypotensive agent in general anaesthesia. Br J Anaesth 42:859–864CrossRefPubMed
17.
Zurück zum Zitat Ivankovich AD, Miletich DJ, Tinker JH (1978) Sodium nitroprusside: metabolism and general considerations. Int Anesthesiol Clin 16:1–29CrossRefPubMed Ivankovich AD, Miletich DJ, Tinker JH (1978) Sodium nitroprusside: metabolism and general considerations. Int Anesthesiol Clin 16:1–29CrossRefPubMed
18.
Zurück zum Zitat Davies DW, Greiss L, Kadar D, Steward DJ (1975) Sodium nitroprusside in children: Observations on metabolism during normal and abnormal responses. Can Anaesth Soc J 22:553–560CrossRefPubMed Davies DW, Greiss L, Kadar D, Steward DJ (1975) Sodium nitroprusside in children: Observations on metabolism during normal and abnormal responses. Can Anaesth Soc J 22:553–560CrossRefPubMed
19.
Zurück zum Zitat Gordillo-Paniagua G, Velasquez Jones L, Martini R, Valdez BE (1975) Sodium nitroprusside treatment of severe arterial hypertension in children. J Pediatr 87:799–802CrossRefPubMed Gordillo-Paniagua G, Velasquez Jones L, Martini R, Valdez BE (1975) Sodium nitroprusside treatment of severe arterial hypertension in children. J Pediatr 87:799–802CrossRefPubMed
20.
Zurück zum Zitat Appelbaum A, Blackstone EH, Kouchoukos NT, Kirklin JW (1977) Afterload reduction and cardiac output in infants early after cardiac surgery. Am J Cardiol 39:445–451PubMedCrossRef Appelbaum A, Blackstone EH, Kouchoukos NT, Kirklin JW (1977) Afterload reduction and cardiac output in infants early after cardiac surgery. Am J Cardiol 39:445–451PubMedCrossRef
21.
Zurück zum Zitat Greiss L, Tremblay NA, Davies DW (1976) The toxicity of sodium nitroprusside. Can Anaesth Soc J 23:480–485PubMedCrossRef Greiss L, Tremblay NA, Davies DW (1976) The toxicity of sodium nitroprusside. Can Anaesth Soc J 23:480–485PubMedCrossRef
22.
Zurück zum Zitat Bailey JM, Miller BE, Kanter KR, Tosone SR, Tam VK (1997) A comparison of the hemodynamic effects of amrinone and sodium nitroprusside in infants after cardiac surgery. Anesth Analg 84:294–298PubMedCrossRef Bailey JM, Miller BE, Kanter KR, Tosone SR, Tam VK (1997) A comparison of the hemodynamic effects of amrinone and sodium nitroprusside in infants after cardiac surgery. Anesth Analg 84:294–298PubMedCrossRef
23.
Zurück zum Zitat Motta P, Mossad E, Toscana D, Zestos M, Mee R (2005) Comparison of phenoxybenzamine to sodium nitroprusside in infants undergoing surgery. J Cardiothorac Vasc Anesth 19:54–59PubMedCrossRef Motta P, Mossad E, Toscana D, Zestos M, Mee R (2005) Comparison of phenoxybenzamine to sodium nitroprusside in infants undergoing surgery. J Cardiothorac Vasc Anesth 19:54–59PubMedCrossRef
24.
Zurück zum Zitat Abbott TR, Rees GJ, Dickinson D, Reynolds G, Lord D (1978) Sodium nitroprusside in idiopathic respiratory distress syndrome. Br Med J 1:1113–1117PubMedPubMedCentralCrossRef Abbott TR, Rees GJ, Dickinson D, Reynolds G, Lord D (1978) Sodium nitroprusside in idiopathic respiratory distress syndrome. Br Med J 1:1113–1117PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Beverley DW, Hughes CA, Davies DP, Harran MJ, Ducker DA (1979) Early use of sodium nitroprusside in respiratory distress syndrome. Arch Dis Child 54:403–404PubMedPubMedCentralCrossRef Beverley DW, Hughes CA, Davies DP, Harran MJ, Ducker DA (1979) Early use of sodium nitroprusside in respiratory distress syndrome. Arch Dis Child 54:403–404PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Benitz WE, Malachowski N, Cohen RS, Stevenson DK, Ariagno RL, Sunshine P (1985) Use of sodium nitroprusside in neonates: efficacy and safety. J Pediatr 106:102–110PubMedCrossRef Benitz WE, Malachowski N, Cohen RS, Stevenson DK, Ariagno RL, Sunshine P (1985) Use of sodium nitroprusside in neonates: efficacy and safety. J Pediatr 106:102–110PubMedCrossRef
27.
Zurück zum Zitat Hammer GB, Connolly SG, Schulman SR et al (2013) Sodium nitroprusside is not associated with metabolic acidosis during intraoperative infusion. BMC Anesthesiol 13:9PubMedPubMedCentralCrossRef Hammer GB, Connolly SG, Schulman SR et al (2013) Sodium nitroprusside is not associated with metabolic acidosis during intraoperative infusion. BMC Anesthesiol 13:9PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Spielberg DR, Barrett JS, Hammer GB et al (2014) Predictors of blood pressure control during deliberate hypotension with sodium nitroprusside in children. Anesth Analg 119:867–874PubMedPubMedCentralCrossRef Spielberg DR, Barrett JS, Hammer GB et al (2014) Predictors of blood pressure control during deliberate hypotension with sodium nitroprusside in children. Anesth Analg 119:867–874PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Hammer GB, Lewandowski A, Drover DR et al (2015) Safety and efficacy of sodium nitroprusside during prolonged infusions in pediatric patients. Pediatr Crit Care Med 16:397–403PubMedCrossRef Hammer GB, Lewandowski A, Drover DR et al (2015) Safety and efficacy of sodium nitroprusside during prolonged infusions in pediatric patients. Pediatr Crit Care Med 16:397–403PubMedCrossRef
30.
Zurück zum Zitat Drover DR, Hammer GB, Barrett JS et al (2015) Evaluation of sodium nitroprusside for controlled hypotension in children during surgery. Front Pharmacol 6:136PubMedPubMedCentralCrossRef Drover DR, Hammer GB, Barrett JS et al (2015) Evaluation of sodium nitroprusside for controlled hypotension in children during surgery. Front Pharmacol 6:136PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Barrett JS, Hirankarn S, Holford N et al (2015) A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children. Front Pharmacol 6:151PubMedPubMedCentralCrossRef Barrett JS, Hirankarn S, Holford N et al (2015) A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children. Front Pharmacol 6:151PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Khambatta HF, Stone JG, Khan E (1979) Hypertension during anesthesia on discontinuation of sodium nitroprusside-induced hypotension. Anesthesiology 51:127–130CrossRefPubMed Khambatta HF, Stone JG, Khan E (1979) Hypertension during anesthesia on discontinuation of sodium nitroprusside-induced hypotension. Anesthesiology 51:127–130CrossRefPubMed
33.
Zurück zum Zitat Rowe GG, Henderson RH (1974) Systemic and coronary hemodynamic effects of sodium nitroprusside. Am Heart J 87:83–87CrossRefPubMed Rowe GG, Henderson RH (1974) Systemic and coronary hemodynamic effects of sodium nitroprusside. Am Heart J 87:83–87CrossRefPubMed
34.
Zurück zum Zitat Sivarajan M, Amory DW, McKenzie SM (1985) Regional blood flows during induced hypotension produced by nitroprusside or trimethaphan in the rhesus monkey. Anesth Analg 64:759–766CrossRefPubMed Sivarajan M, Amory DW, McKenzie SM (1985) Regional blood flows during induced hypotension produced by nitroprusside or trimethaphan in the rhesus monkey. Anesth Analg 64:759–766CrossRefPubMed
35.
Zurück zum Zitat Michenfelder JD, Milde JH (1988) The interaction of sodium nitroprusside hypotension and isoflurane in determining cerebral vasculature effects. Anesthesiology 69:870–875CrossRefPubMed Michenfelder JD, Milde JH (1988) The interaction of sodium nitroprusside hypotension and isoflurane in determining cerebral vasculature effects. Anesthesiology 69:870–875CrossRefPubMed
36.
Zurück zum Zitat Hines R, Barash P (1989) Infusion of sodium nitroprusside induces platelet dysfunction in vitro. Anesthesiology 70:611–615CrossRefPubMed Hines R, Barash P (1989) Infusion of sodium nitroprusside induces platelet dysfunction in vitro. Anesthesiology 70:611–615CrossRefPubMed
37.
Zurück zum Zitat Rawlingson WAL, Loach AB, Benedict CR (1978) Changes in plasma concentration of adrenaline and noradrenaline in anesthetized patients during sodium nitroprusside-induced hypotension. Br J Anaesth 50:937–942CrossRef Rawlingson WAL, Loach AB, Benedict CR (1978) Changes in plasma concentration of adrenaline and noradrenaline in anesthetized patients during sodium nitroprusside-induced hypotension. Br J Anaesth 50:937–942CrossRef
38.
Zurück zum Zitat Thomas C, Svehla L, Moffett BS (2009) Sodium nitroprusside-induced cyanide toxicity in pediatric patients. Expert Opin Drug Safe 8:599–602CrossRef Thomas C, Svehla L, Moffett BS (2009) Sodium nitroprusside-induced cyanide toxicity in pediatric patients. Expert Opin Drug Safe 8:599–602CrossRef
39.
Zurück zum Zitat Moffett BS, Price JF (2008) Evaluation of sodium nitroprusside toxicity in pediatric cardiac surgical patients. Ann Pharmacother 42:1600–1604CrossRefPubMed Moffett BS, Price JF (2008) Evaluation of sodium nitroprusside toxicity in pediatric cardiac surgical patients. Ann Pharmacother 42:1600–1604CrossRefPubMed
40.
Zurück zum Zitat Hottinger DG, Beebe DS, Kozhimannil T, Prielipp RC, Belani KG (2014) Sodium nitroprusside in 2014: a clinical concepts review. J Anaesthesiol Clin Pharmacol 30:462–471PubMedPubMedCentralCrossRef Hottinger DG, Beebe DS, Kozhimannil T, Prielipp RC, Belani KG (2014) Sodium nitroprusside in 2014: a clinical concepts review. J Anaesthesiol Clin Pharmacol 30:462–471PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Chen Z, Zhang J, Stamler JS (2002) Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci USA 99:8306–8311CrossRefPubMedPubMedCentral Chen Z, Zhang J, Stamler JS (2002) Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci USA 99:8306–8311CrossRefPubMedPubMedCentral
42.
43.
Zurück zum Zitat Fahmy NR (1978) Nitroglycerin as a hypotensive agent drug during general anesthesia. Anesthesiology 49:17–20CrossRefPubMed Fahmy NR (1978) Nitroglycerin as a hypotensive agent drug during general anesthesia. Anesthesiology 49:17–20CrossRefPubMed
44.
Zurück zum Zitat Cottrell JE, Gupta B, Rappaport H et al (1980) Intracranial pressure during nitroglycerin-induced hypotension. J Neurosurg 53:309–311CrossRefPubMed Cottrell JE, Gupta B, Rappaport H et al (1980) Intracranial pressure during nitroglycerin-induced hypotension. J Neurosurg 53:309–311CrossRefPubMed
45.
Zurück zum Zitat Lagerkranser M (1992) Effects of nitroglycerin on intracranial pressure and cerebral blood flow. Acta Anaesth Scand 36:34–36CrossRef Lagerkranser M (1992) Effects of nitroglycerin on intracranial pressure and cerebral blood flow. Acta Anaesth Scand 36:34–36CrossRef
46.
Zurück zum Zitat Nam YT, Shin T, Yoshitake J (1898) Induced hypotension for surgical repair of congenital dislocation of the hip in children. J Anesth 3:58–64CrossRef Nam YT, Shin T, Yoshitake J (1898) Induced hypotension for surgical repair of congenital dislocation of the hip in children. J Anesth 3:58–64CrossRef
47.
Zurück zum Zitat Yaster M, Simmons RS, Tolo VT, Pepple JM, Wetzel RC, Rogers MC (1986) A comparison of nitroglycerin and nitroprusside for inducing hypotension in children: a double blind study. Anesthesiology 65:175–179CrossRefPubMed Yaster M, Simmons RS, Tolo VT, Pepple JM, Wetzel RC, Rogers MC (1986) A comparison of nitroglycerin and nitroprusside for inducing hypotension in children: a double blind study. Anesthesiology 65:175–179CrossRefPubMed
48.
Zurück zum Zitat Ilbawi MN, Idriss FS, DeLeon SY, Berry TE, Duffy CE, Paul MH (1985) Hemodynamic effects of intravenous nitroglycerin in pediatric patients after heart surgery. Circulation 72(3):2101–2107 Ilbawi MN, Idriss FS, DeLeon SY, Berry TE, Duffy CE, Paul MH (1985) Hemodynamic effects of intravenous nitroglycerin in pediatric patients after heart surgery. Circulation 72(3):2101–2107
49.
Zurück zum Zitat Zeng H, Sun L, Li W, Du J (2000) Effect of intravenous nitroglycerin on hemodynamics in infants and children with congestive heart failure. Chin Med J 113:328–331PubMed Zeng H, Sun L, Li W, Du J (2000) Effect of intravenous nitroglycerin on hemodynamics in infants and children with congestive heart failure. Chin Med J 113:328–331PubMed
50.
Zurück zum Zitat Edmondson R, Del Valle O, Shah N et al (1989) Esmolol for the potentiation of nitroprusside-induced hypotension: impact on the cardiovascular adrenergic and renin-angiotensin system in man. Anesth Analg 69:202–206CrossRefPubMed Edmondson R, Del Valle O, Shah N et al (1989) Esmolol for the potentiation of nitroprusside-induced hypotension: impact on the cardiovascular adrenergic and renin-angiotensin system in man. Anesth Analg 69:202–206CrossRefPubMed
51.
Zurück zum Zitat Ishisaka DY, Yonan CD, Housel BF (1991) Labetolol for treatment of hypertension in a child. Clin Pharm 10:500–501PubMed Ishisaka DY, Yonan CD, Housel BF (1991) Labetolol for treatment of hypertension in a child. Clin Pharm 10:500–501PubMed
52.
Zurück zum Zitat MacCarthy EP, Bloomfield SS (1983) Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects. Pharmacotherapy 3:193–219CrossRefPubMed MacCarthy EP, Bloomfield SS (1983) Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects. Pharmacotherapy 3:193–219CrossRefPubMed
53.
Zurück zum Zitat Cottrell JE, Patel K, Turndorf H, Ransohoff J (1978) Intracranial pressure changes induced by sodium nitroprusside in patients with intracranial mass lesions. J Neurosurg 48:329–331CrossRefPubMed Cottrell JE, Patel K, Turndorf H, Ransohoff J (1978) Intracranial pressure changes induced by sodium nitroprusside in patients with intracranial mass lesions. J Neurosurg 48:329–331CrossRefPubMed
54.
Zurück zum Zitat Turner JM, Powell D, Gibson RM, McDowall DG (1977) Intracranial pressure changes in neurosurgical patients during hypotension induced with sodium nitroprusside or trimetaphan. Br J Anaesth 49:419–423CrossRefPubMed Turner JM, Powell D, Gibson RM, McDowall DG (1977) Intracranial pressure changes in neurosurgical patients during hypotension induced with sodium nitroprusside or trimetaphan. Br J Anaesth 49:419–423CrossRefPubMed
55.
Zurück zum Zitat Rose JC, Mayer SA (2004) Optimizing blood pressure in neurological emergencies. Neuro Crit Care 1:287–299 Rose JC, Mayer SA (2004) Optimizing blood pressure in neurological emergencies. Neuro Crit Care 1:287–299
56.
Zurück zum Zitat Orlowski JP, Shiesley D, Vidt DG et al (1988) Labetolol to control blood pressure after cerebrovascular surgery. Crit Care Med 16:765–768CrossRefPubMed Orlowski JP, Shiesley D, Vidt DG et al (1988) Labetolol to control blood pressure after cerebrovascular surgery. Crit Care Med 16:765–768CrossRefPubMed
57.
Zurück zum Zitat Jones SEF (1979) Controlled hypotension using labetolol and halothane. Anaesthesia 34:1052–1055CrossRefPubMed Jones SEF (1979) Controlled hypotension using labetolol and halothane. Anaesthesia 34:1052–1055CrossRefPubMed
58.
Zurück zum Zitat Bojar RM, Weiner B, Cleveland RJ (1988) Intravenous labetolol for the control of hypertension following repair of coarctation of the aorta. Clin Cardiol 11:639–641CrossRefPubMed Bojar RM, Weiner B, Cleveland RJ (1988) Intravenous labetolol for the control of hypertension following repair of coarctation of the aorta. Clin Cardiol 11:639–641CrossRefPubMed
60.
Zurück zum Zitat Bunchman TE, Lynch RE, Wood EG (1992) Intravenously administered labetolol for treatment of hypertension in children. J Pediatr 120:140–144CrossRefPubMed Bunchman TE, Lynch RE, Wood EG (1992) Intravenously administered labetolol for treatment of hypertension in children. J Pediatr 120:140–144CrossRefPubMed
61.
Zurück zum Zitat Thomas CA, Moffett BS, Wahner JL, Mott AR, Feig DI (2011) Safety and efficacy of intravenous labetolol for hypertensive crisis in infants and small children. Pediatr Crit Care Med 12:28–32CrossRefPubMed Thomas CA, Moffett BS, Wahner JL, Mott AR, Feig DI (2011) Safety and efficacy of intravenous labetolol for hypertensive crisis in infants and small children. Pediatr Crit Care Med 12:28–32CrossRefPubMed
62.
Zurück zum Zitat De Hert S, Boeckx E, Vercauteren M, Claes J, Van den Heyning P, Adriaensen H (1989) Safety of labetalol-induced controlled hypotension during middle ear microsurgery. Acta Otorhinolaryngol Belg 43:157–162PubMed De Hert S, Boeckx E, Vercauteren M, Claes J, Van den Heyning P, Adriaensen H (1989) Safety of labetalol-induced controlled hypotension during middle ear microsurgery. Acta Otorhinolaryngol Belg 43:157–162PubMed
63.
Zurück zum Zitat Arthur S, Greenberg A (1990) Hyperkalemia associated with intravenous labetalol therapy for acute hypertensions in renal transplant recipients. Brlin Nephrol 33:269–271 Arthur S, Greenberg A (1990) Hyperkalemia associated with intravenous labetalol therapy for acute hypertensions in renal transplant recipients. Brlin Nephrol 33:269–271
64.
Zurück zum Zitat Hesse B, Pedersen JT (1973) Hypoglycaemia after propranolol in children. Acta Med Scand 193:551–552CrossRefPubMed Hesse B, Pedersen JT (1973) Hypoglycaemia after propranolol in children. Acta Med Scand 193:551–552CrossRefPubMed
65.
Zurück zum Zitat Clark JA, Zimmerman HJ, Tanner LA (1990) Labetalol hepatotoxicity. Ann Intern Med 113:210–213CrossRefPubMed Clark JA, Zimmerman HJ, Tanner LA (1990) Labetalol hepatotoxicity. Ann Intern Med 113:210–213CrossRefPubMed
66.
Zurück zum Zitat Angaran DM, Schultz NJ, Tschida VH (1986) Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent. Clin Pharm 5:288–303PubMed Angaran DM, Schultz NJ, Tschida VH (1986) Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent. Clin Pharm 5:288–303PubMed
67.
Zurück zum Zitat Cuneo BF, Zales VR, Blahunka PC, Benson DW (1994) Pharmacodynamics and pharmacokinetics of esmolol, a short-acting beta-blocking agent, in children. Pediatr Cardiol 15:296–301CrossRefPubMed Cuneo BF, Zales VR, Blahunka PC, Benson DW (1994) Pharmacodynamics and pharmacokinetics of esmolol, a short-acting beta-blocking agent, in children. Pediatr Cardiol 15:296–301CrossRefPubMed
68.
Zurück zum Zitat Reynolds RD, Gorczynski RJ, Quon CY (1986) Pharmacology and pharmacokinetics of esmolol. J Clin Pharmacol 26:A3–A14CrossRefPubMed Reynolds RD, Gorczynski RJ, Quon CY (1986) Pharmacology and pharmacokinetics of esmolol. J Clin Pharmacol 26:A3–A14CrossRefPubMed
69.
Zurück zum Zitat Wiest DB, Trippel DL, Gillette PC, Garner SS (1991) Pharmacokinetics of esmolol in children. Clin Pharmacol Ther 49:618–623CrossRefPubMed Wiest DB, Trippel DL, Gillette PC, Garner SS (1991) Pharmacokinetics of esmolol in children. Clin Pharmacol Ther 49:618–623CrossRefPubMed
70.
Zurück zum Zitat Trippel DL, Wiest DB, Gillette PC (1991) Cardiovascular and antiarrhythmic effects of esmolol in children. J Pediatr 119:142–147CrossRefPubMed Trippel DL, Wiest DB, Gillette PC (1991) Cardiovascular and antiarrhythmic effects of esmolol in children. J Pediatr 119:142–147CrossRefPubMed
71.
Zurück zum Zitat Adamson PC, Rhodes LA, Saul JP, Dick M 2nd, Epstein MR, Moate P, Boston R, Schreiner MS (2006) The pharmacokinetics of esmolol in pediatric subjects with supraventricular arrhythmias. Pediatr Cardiol 27:420–427CrossRefPubMed Adamson PC, Rhodes LA, Saul JP, Dick M 2nd, Epstein MR, Moate P, Boston R, Schreiner MS (2006) The pharmacokinetics of esmolol in pediatric subjects with supraventricular arrhythmias. Pediatr Cardiol 27:420–427CrossRefPubMed
72.
Zurück zum Zitat Sum CY, Yacobi A, Kartzinel R, Stampfli H, Davis CS, Lai CM (1983) Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite. Clin Pharmacol Ther 34:427–434CrossRefPubMed Sum CY, Yacobi A, Kartzinel R, Stampfli H, Davis CS, Lai CM (1983) Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite. Clin Pharmacol Ther 34:427–434CrossRefPubMed
73.
Zurück zum Zitat Smerling A, Gersony WM (1990) Esmolol for severe hypertension following repair of aortic coarctation. Crit Care Med 18:1288–1290CrossRefPubMed Smerling A, Gersony WM (1990) Esmolol for severe hypertension following repair of aortic coarctation. Crit Care Med 18:1288–1290CrossRefPubMed
74.
Zurück zum Zitat Vincent RN, Click LA, Willliams HM, Plauth WH, Williams WH (1990) Esmolol as an adjunct in the treatment of systemic hypertension after operative repair of coarctation of the aorta. Am J Cardiol 65:941–943CrossRefPubMed Vincent RN, Click LA, Willliams HM, Plauth WH, Williams WH (1990) Esmolol as an adjunct in the treatment of systemic hypertension after operative repair of coarctation of the aorta. Am J Cardiol 65:941–943CrossRefPubMed
75.
Zurück zum Zitat Wiest DB, Garner SS, Uber WE, Sade RM (1998) Esmolol for the management of pediatric hypertension after cardiac operations. J Thorac Cardiovasc Surg 115:890–897CrossRefPubMed Wiest DB, Garner SS, Uber WE, Sade RM (1998) Esmolol for the management of pediatric hypertension after cardiac operations. J Thorac Cardiovasc Surg 115:890–897CrossRefPubMed
76.
Zurück zum Zitat Tabbutt S, Nicolson SC, Adamson PC et al (2008) The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial. J Thorac Cardiovasc Surg 136:321–328CrossRefPubMed Tabbutt S, Nicolson SC, Adamson PC et al (2008) The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial. J Thorac Cardiovasc Surg 136:321–328CrossRefPubMed
77.
Zurück zum Zitat Chao T, Perry JC, Romanowski GL, Tremoulet AH, Capparelli EV (2014) Optimizing pediatric esmolol dosing using computerized practitioner order entry. J Pediatr Pharmacol Ther 19:302–309PubMedPubMedCentral Chao T, Perry JC, Romanowski GL, Tremoulet AH, Capparelli EV (2014) Optimizing pediatric esmolol dosing using computerized practitioner order entry. J Pediatr Pharmacol Ther 19:302–309PubMedPubMedCentral
78.
Zurück zum Zitat Tobias JD, Sauder RA, Hirshman CA (1990) Pulmonary reactivity to methacholine during beta-adrenergic blockade: propranolol versus esmolol. Anesthesiology 73:132–136CrossRefPubMed Tobias JD, Sauder RA, Hirshman CA (1990) Pulmonary reactivity to methacholine during beta-adrenergic blockade: propranolol versus esmolol. Anesthesiology 73:132–136CrossRefPubMed
80.
Zurück zum Zitat Sibley DR, Monsma FJ Jr (1992) Molecular biology of dopamine receptors. Trends Pharmacol Sci 13:61–69CrossRefPubMed Sibley DR, Monsma FJ Jr (1992) Molecular biology of dopamine receptors. Trends Pharmacol Sci 13:61–69CrossRefPubMed
81.
Zurück zum Zitat Murphy MB, Murray C, Shorten GD (2001) Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med 345:1548–1557CrossRefPubMed Murphy MB, Murray C, Shorten GD (2001) Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med 345:1548–1557CrossRefPubMed
82.
Zurück zum Zitat Pilmer BL, Green JA, Panacek EA, Elliot WJ, Murphy MB, Rutherford W, Nara AR (1993) Fenoldopam mesylate versus sodium nitroprusside in the acute management of severe systemic hypertension. J Clin Pharmacol 33:549–553CrossRefPubMed Pilmer BL, Green JA, Panacek EA, Elliot WJ, Murphy MB, Rutherford W, Nara AR (1993) Fenoldopam mesylate versus sodium nitroprusside in the acute management of severe systemic hypertension. J Clin Pharmacol 33:549–553CrossRefPubMed
83.
Zurück zum Zitat Strauser LM, Pruitt RD, Tobias JD (1999) Initial experience with fenoldopam in children. Am J Ther 6:283–288CrossRefPubMed Strauser LM, Pruitt RD, Tobias JD (1999) Initial experience with fenoldopam in children. Am J Ther 6:283–288CrossRefPubMed
84.
Zurück zum Zitat Tobias JD (2000) Fenoldopam for controlled hypotension during spinal fusion in children and adolescents. Paediatr Anaesth 10:261–266CrossRefPubMed Tobias JD (2000) Fenoldopam for controlled hypotension during spinal fusion in children and adolescents. Paediatr Anaesth 10:261–266CrossRefPubMed
85.
Zurück zum Zitat Hammer GB, Verghese ST, Drover DR, Yaster M, Tobin JR (2008) Pharmacokinetics and pharmacodynamics of fenoldopam mesylate for blood pressure control in pediatric patients. BMC Anesthesiol 8:6PubMedPubMedCentralCrossRef Hammer GB, Verghese ST, Drover DR, Yaster M, Tobin JR (2008) Pharmacokinetics and pharmacodynamics of fenoldopam mesylate for blood pressure control in pediatric patients. BMC Anesthesiol 8:6PubMedPubMedCentralCrossRef
86.
Zurück zum Zitat Moffett BS, Mott AR, Nelson DP, Goldstein SL, Jefferies JL (2008) Renal effects of fenoldopam in critically ill pediatric patients: a retrospective review. Pediatr Crit Care Med 9:403–406CrossRefPubMed Moffett BS, Mott AR, Nelson DP, Goldstein SL, Jefferies JL (2008) Renal effects of fenoldopam in critically ill pediatric patients: a retrospective review. Pediatr Crit Care Med 9:403–406CrossRefPubMed
87.
Zurück zum Zitat Costello JM, Thiagarajan RR, Dionne RE, Allan CK, Booth KL, Burmester M, Wessel DL, Laussen PC (2006) Initial experience with fenoldopam after cardiac surgery in neonates with an insufficient response to conventional diuretics. Pediatr Crit Care Med 7:28–33CrossRefPubMed Costello JM, Thiagarajan RR, Dionne RE, Allan CK, Booth KL, Burmester M, Wessel DL, Laussen PC (2006) Initial experience with fenoldopam after cardiac surgery in neonates with an insufficient response to conventional diuretics. Pediatr Crit Care Med 7:28–33CrossRefPubMed
88.
Zurück zum Zitat Ricci Z, Stazi GV, Di Chiara L, Morelli S, Vitale V, Giorni C, Ronco C, Picardo S (2008) Fenoldopam in newborn patients undergoing cardiopulmonary bypass: controlled clinical trial. Interact Cardiovasc Thorac Surg 7:1049–1053CrossRefPubMed Ricci Z, Stazi GV, Di Chiara L, Morelli S, Vitale V, Giorni C, Ronco C, Picardo S (2008) Fenoldopam in newborn patients undergoing cardiopulmonary bypass: controlled clinical trial. Interact Cardiovasc Thorac Surg 7:1049–1053CrossRefPubMed
89.
Zurück zum Zitat Morelli A, Ricci Z, Bellomo R, Ronco C, Rocco M, Conti G, De Gaetano A, Picchini U, Orecchioni A, Portieri M, Coluzzi F, Porzi P, Serio P, Bruno A, Pietropaoli P (2005) Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial. Crit Care Med 33:2451–2456CrossRefPubMed Morelli A, Ricci Z, Bellomo R, Ronco C, Rocco M, Conti G, De Gaetano A, Picchini U, Orecchioni A, Portieri M, Coluzzi F, Porzi P, Serio P, Bruno A, Pietropaoli P (2005) Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial. Crit Care Med 33:2451–2456CrossRefPubMed
90.
91.
Zurück zum Zitat Clarke B, Eglen RM, Patmore L, Whiting RL (1983) Cardioselective calcium channel entry blocking properties of nicardipine, nifedipine, and PY-108068 on cardiac and vascular smooth muscle. Br J Pharmacol 79:333P–P337 Clarke B, Eglen RM, Patmore L, Whiting RL (1983) Cardioselective calcium channel entry blocking properties of nicardipine, nifedipine, and PY-108068 on cardiac and vascular smooth muscle. Br J Pharmacol 79:333P–P337
92.
Zurück zum Zitat Lambert CR, Hill JA, Nichols WW, Feldman RL, Pepine CJ (1985) Coronary and systemic hemodynamic effects of nicardipine. Am J Cardiol 55:652–656PubMedCrossRef Lambert CR, Hill JA, Nichols WW, Feldman RL, Pepine CJ (1985) Coronary and systemic hemodynamic effects of nicardipine. Am J Cardiol 55:652–656PubMedCrossRef
93.
Zurück zum Zitat Rousseau MF, Etienne J, Van Mechelen H, Veriter C, Pouleur H (1984) Hemodynamic and cardiac effects of nicardipine in patients with coronary artery disease. J Cardiovasc Pharmacol 6:833–839PubMedCrossRef Rousseau MF, Etienne J, Van Mechelen H, Veriter C, Pouleur H (1984) Hemodynamic and cardiac effects of nicardipine in patients with coronary artery disease. J Cardiovasc Pharmacol 6:833–839PubMedCrossRef
94.
Zurück zum Zitat Treluyer JM, Hubert P, Jouvet P, Couderc S, Cloup M (1993) Intravenous nicardipine in hypertensive children. Eur J Paediatr 152:712–714CrossRef Treluyer JM, Hubert P, Jouvet P, Couderc S, Cloup M (1993) Intravenous nicardipine in hypertensive children. Eur J Paediatr 152:712–714CrossRef
95.
Zurück zum Zitat Tobias JD, Lowe S, Deshpande JK (1995) Nicardipine: perioperative applications in children. Paediatr Anaesth 5:171–176PubMedCrossRef Tobias JD, Lowe S, Deshpande JK (1995) Nicardipine: perioperative applications in children. Paediatr Anaesth 5:171–176PubMedCrossRef
96.
Zurück zum Zitat Tobias JD (1996) Nicardipine to control mean arterial pressure in a pediatric intensive care unit population. Am J Anesthesiol 23:109–112 Tobias JD (1996) Nicardipine to control mean arterial pressure in a pediatric intensive care unit population. Am J Anesthesiol 23:109–112
97.
Zurück zum Zitat Michael J, Groshong T, Tobias JD (1998) Nicardipine for hypertensive emergencies in children with renal disease. Pediatr Nephrol 12:40–42PubMedCrossRef Michael J, Groshong T, Tobias JD (1998) Nicardipine for hypertensive emergencies in children with renal disease. Pediatr Nephrol 12:40–42PubMedCrossRef
98.
Zurück zum Zitat Tenney F, Sakarcan A (2000) Nicardipine is a safe and effective agent in pediatric hypertensive emergencies. Am J Kid Dis 35:E20PubMedCrossRef Tenney F, Sakarcan A (2000) Nicardipine is a safe and effective agent in pediatric hypertensive emergencies. Am J Kid Dis 35:E20PubMedCrossRef
99.
Zurück zum Zitat Flynn JT, Mottes TA, Brophy PD, Kershaw DB, Smoyer WE, Bunchman TE (2001) Intravenous nicardipine for treatment of severe hypertension in children. J Pediatr 139:38–43PubMedCrossRef Flynn JT, Mottes TA, Brophy PD, Kershaw DB, Smoyer WE, Bunchman TE (2001) Intravenous nicardipine for treatment of severe hypertension in children. J Pediatr 139:38–43PubMedCrossRef
100.
Zurück zum Zitat Hersey SL, O'Dell NE, Lowe S, Rasmussen G, Tobias JD, Deshpande JK, Mencio G, Green N (1997) Nicardipine versus nitroprusside for controlled hypotension during spinal surgery in adolescents. Anesth Analg 84:1239–1244PubMedCrossRef Hersey SL, O'Dell NE, Lowe S, Rasmussen G, Tobias JD, Deshpande JK, Mencio G, Green N (1997) Nicardipine versus nitroprusside for controlled hypotension during spinal surgery in adolescents. Anesth Analg 84:1239–1244PubMedCrossRef
101.
Zurück zum Zitat Tobias JD, Hersey S, Mencio GA, Green NE (1996) Nicardipine for controlled hypotension during spinal surgery. J Pediatr Orthop 16:370–373PubMedCrossRef Tobias JD, Hersey S, Mencio GA, Green NE (1996) Nicardipine for controlled hypotension during spinal surgery. J Pediatr Orthop 16:370–373PubMedCrossRef
102.
Zurück zum Zitat Tobias JD (2001) Nicardipine to control mean arterial pressure after cardiothoracic surgery in infants and children. Am J Ther 8:3–6PubMedCrossRef Tobias JD (2001) Nicardipine to control mean arterial pressure after cardiothoracic surgery in infants and children. Am J Ther 8:3–6PubMedCrossRef
103.
Zurück zum Zitat Nakagawa TA, Sartori SC, Morris A, Schneider DS (2004) Intravenous nicardipine for treatment of postcoarctectomy hypertension in children. Pediatr Cardiol 25:26–30PubMedCrossRef Nakagawa TA, Sartori SC, Morris A, Schneider DS (2004) Intravenous nicardipine for treatment of postcoarctectomy hypertension in children. Pediatr Cardiol 25:26–30PubMedCrossRef
104.
Zurück zum Zitat Mastroprietro CW, Uribe DA (2016) Nicardipine for hypertension following aortic coarctectomy or superior cavopulmonary anastomosis. World J Pediatr Congenit Heart Surg 7:32–35CrossRef Mastroprietro CW, Uribe DA (2016) Nicardipine for hypertension following aortic coarctectomy or superior cavopulmonary anastomosis. World J Pediatr Congenit Heart Surg 7:32–35CrossRef
105.
Zurück zum Zitat Stone ML, Kelly J, Mistry M, Buck M, Gangemi J, Vergales J (2018) Use of nicardipine after cardiac operations is safe in children regardless of age. Ann Thorac Surg 105:181–185PubMedCrossRef Stone ML, Kelly J, Mistry M, Buck M, Gangemi J, Vergales J (2018) Use of nicardipine after cardiac operations is safe in children regardless of age. Ann Thorac Surg 105:181–185PubMedCrossRef
106.
Zurück zum Zitat Epstein ML, Kiel EA, Victorica BE (1985) Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia. Pediatrics 75:737–740PubMedCrossRef Epstein ML, Kiel EA, Victorica BE (1985) Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia. Pediatrics 75:737–740PubMedCrossRef
107.
108.
Zurück zum Zitat Gouyon JB, Geneste B, Semama DS, Francoise M, Germain JF (1997) Intravenous nicardipine in hypertensive preterm infants. Arch Dis Child Fetal Neonatal Ed 76:F126–F127PubMedPubMedCentralCrossRef Gouyon JB, Geneste B, Semama DS, Francoise M, Germain JF (1997) Intravenous nicardipine in hypertensive preterm infants. Arch Dis Child Fetal Neonatal Ed 76:F126–F127PubMedPubMedCentralCrossRef
109.
Zurück zum Zitat Milou C, Debuche-Benouachkou V, Semama DS, Germain JF, Gouyon JB (2000) Intravenous nicardipine as a firstline antihypertensive drug in neonates. Intensive Care Med 26:956–958PubMedCrossRef Milou C, Debuche-Benouachkou V, Semama DS, Germain JF, Gouyon JB (2000) Intravenous nicardipine as a firstline antihypertensive drug in neonates. Intensive Care Med 26:956–958PubMedCrossRef
110.
Zurück zum Zitat Bernard JM, Pinaud M, François T, Babin M, Macquin-Mavier I, Letenneur J (1991) Deliberate hypotension with nicardipine or nitroprusside during total hip arthroplasty. Anesth Analg 73:341–345CrossRefPubMed Bernard JM, Pinaud M, François T, Babin M, Macquin-Mavier I, Letenneur J (1991) Deliberate hypotension with nicardipine or nitroprusside during total hip arthroplasty. Anesth Analg 73:341–345CrossRefPubMed
111.
Zurück zum Zitat Bernard JM, Passuti N, Pinaud M (1992) Long-term hypotensive technique with nicardipine and nitroprusside during isoflurane anesthesia for spinal surgery. Anesth Analg 75:179–185CrossRefPubMed Bernard JM, Passuti N, Pinaud M (1992) Long-term hypotensive technique with nicardipine and nitroprusside during isoflurane anesthesia for spinal surgery. Anesth Analg 75:179–185CrossRefPubMed
112.
Zurück zum Zitat Levy JH, Mancao MY, Gitter R et al (2007) Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery. Anesth Analg 105:918–925CrossRefPubMed Levy JH, Mancao MY, Gitter R et al (2007) Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery. Anesth Analg 105:918–925CrossRefPubMed
113.
Zurück zum Zitat Singla N, Warltier DC, Gandhi SD et al (2008) Treatment of acute postoperative hypertension in cardiac surgery patients: An efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial. Anesth Analg 107:59–67CrossRefPubMed Singla N, Warltier DC, Gandhi SD et al (2008) Treatment of acute postoperative hypertension in cardiac surgery patients: An efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial. Anesth Analg 107:59–67CrossRefPubMed
114.
Zurück zum Zitat Aronson S, Dyke CM, Stierer KA et al (2008) The ECLIPSE trials: Comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg 107:1110–1121CrossRefPubMed Aronson S, Dyke CM, Stierer KA et al (2008) The ECLIPSE trials: Comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg 107:1110–1121CrossRefPubMed
115.
Zurück zum Zitat Tobias JD, Allee J, Ramachandran V, Groshong T (2009) Clevidipine controls intraoperative blood pressure in an adolescent with renal failure. J Pediatr Pharmacol Ther 14:144–147PubMedPubMedCentral Tobias JD, Allee J, Ramachandran V, Groshong T (2009) Clevidipine controls intraoperative blood pressure in an adolescent with renal failure. J Pediatr Pharmacol Ther 14:144–147PubMedPubMedCentral
116.
Zurück zum Zitat Towe E, Tobias JD (2010) Preliminary experience with clevidipine in the pediatric population. J Intensive Care Med 25:349–352CrossRefPubMed Towe E, Tobias JD (2010) Preliminary experience with clevidipine in the pediatric population. J Intensive Care Med 25:349–352CrossRefPubMed
117.
Zurück zum Zitat Bettesworth JG, Martin DP, Tobias JD (2013) Intraoperative use of clevidipine in a patient with von Hippel-Lindau disease with associated pheochromocytoma. J Cardiothorac Vasc Anesth 27:749–751CrossRefPubMed Bettesworth JG, Martin DP, Tobias JD (2013) Intraoperative use of clevidipine in a patient with von Hippel-Lindau disease with associated pheochromocytoma. J Cardiothorac Vasc Anesth 27:749–751CrossRefPubMed
118.
Zurück zum Zitat Tobias JD, Schechter WS, Phillips A, Weinstein S, Michler R, Berkenbosch JW, Montoya C (2011) Clevidipine for perioperative blood pressure control in infants and children undergoing cardiac surgery for congenital heart disease. J Pediatr Pharmacol Ther 16:55–60PubMedPubMedCentral Tobias JD, Schechter WS, Phillips A, Weinstein S, Michler R, Berkenbosch JW, Montoya C (2011) Clevidipine for perioperative blood pressure control in infants and children undergoing cardiac surgery for congenital heart disease. J Pediatr Pharmacol Ther 16:55–60PubMedPubMedCentral
119.
Zurück zum Zitat Tobias JD, Hoernschemeyer DG (2011) Clevidipine for controlled hypotension during spinal surgery in adolescents. J Neurosurg Anesthesiol 23:347–351CrossRefPubMed Tobias JD, Hoernschemeyer DG (2011) Clevidipine for controlled hypotension during spinal surgery in adolescents. J Neurosurg Anesthesiol 23:347–351CrossRefPubMed
Metadaten
Titel
Pharmacologic Control of Blood Pressure in Infants and Children
verfasst von
Joseph D. Tobias
Aymen Naguib
Janet Simsic
Catherine D. Krawczeski
Publikationsdatum
11.09.2020
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 7/2020
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-020-02448-2

Weitere Artikel der Ausgabe 7/2020

Pediatric Cardiology 7/2020 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.